- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/68 - Stabilisation of the vector
Patent holdings for IPC class C12N 15/68
Total number of patents in this class: 157
10-year publication summary
|
8
|
8
|
14
|
8
|
5
|
10
|
10
|
11
|
8
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Curevac SE | 281 |
12 |
| BioNTech SE | 766 |
7 |
| Curevac GmbH | 50 |
4 |
| International AIDS Vaccine Initiative | 92 |
4 |
| Tron - Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg- Universitat Mainz gGmbH | 59 |
4 |
| BlueAllele, LLC | 18 |
4 |
| Massachusetts Institute of Technology | 10190 |
3 |
| Case Western Reserve University | 1865 |
3 |
| CureVac AG | 128 |
3 |
| King Faisal Specialist Hospital and Research Centre | 10 |
3 |
| National University of Singapore | 2550 |
3 |
| RinuaGene Biotechnology Co., Ltd. | 31 |
3 |
| Rinuagene International HK Limited | 29 |
3 |
| BASF SE | 21131 |
2 |
| Ambrx, Inc. | 172 |
2 |
| BioNTech AG | 74 |
2 |
| BioNTech RNA Pharmaceuticals GmbH | 72 |
2 |
| Ethris GmbH | 98 |
2 |
| Fuso Pharmaceutical Industries, Ltd. | 121 |
2 |
| National University Corporation Hokkaido University | 1348 |
2 |
| Other owners | 87 |